Insider: KOZARICH JOHN W Director - LIGAND PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 42,253 | 0 | 42,253 |
| Value | $8,433,276.27 | $0.00 | $8,433,276.27 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 04/01/2026 | DDS | 159 | Direct | COM | $204.26 | $32,477.77 | 42,253 |
| 04/01/2026 | DDS | 146 | Direct | COM | $199.97 | $29,196.34 | 42,574 |
| 04/01/2026 | DDS | 40 | Direct | COM | $201.24 | $8,049.40 | 42,534 |
| 04/01/2026 | DDS | 43 | Direct | COM | $202.91 | $8,725.22 | 42,412 |
| 04/01/2026 | DDS | 79 | Direct | COM | $202.42 | $15,991.36 | 42,455 |
| 03/02/2026 | DDS | 47 | Direct | COM | $197.14 | $9,265.57 | 43,140 |
| 03/02/2026 | DDS | 204 | Direct | COM | $199.69 | $40,736.64 | 42,936 |
| 03/02/2026 | DDS | 41 | Direct | COM | $200.40 | $8,216.56 | 42,895 |
| 03/02/2026 | DDS | 42 | Direct | COM | $203.57 | $8,549.94 | 42,720 |
| 03/02/2026 | DDS | 50 | Direct | COM | $202.54 | $10,126.94 | 42,762 |
| 03/02/2026 | DDS | 83 | Direct | COM | $201.65 | $16,736.72 | 42,812 |
| 02/02/2026 | DDS | 39 | Direct | COM | $191.00 | $7,449.00 | 43,615 |
| 02/02/2026 | DDS | 1 | Direct | COM | $192.18 | $192.18 | 43,614 |
| 02/02/2026 | DDS | 381 | Direct | COM | $196.36 | $74,814.46 | 43,210 |
| 02/02/2026 | DDS | 23 | Direct | COM | $197.20 | $4,535.49 | 43,187 |
| 02/02/2026 | DDS | 23 | Direct | COM | $195.61 | $4,498.92 | 43,591 |
| 01/02/2026 | DDS | 91 | Direct | COM | $187.95 | $17,103.78 | 44,009 |
| 01/02/2026 | DDS | 102 | Direct | COM | $188.96 | $19,274.20 | 43,907 |
| 01/02/2026 | DDS | 21 | Direct | COM | $186.59 | $3,918.39 | 44,100 |
| 01/02/2026 | DDS | 46 | Direct | COM | $192.40 | $8,850.17 | 43,654 |
| 01/02/2026 | DDS | 207 | Direct | COM | $190.27 | $39,385.95 | 43,700 |
| 12/01/2025 | DDS | 179 | Direct | COM | $194.76 | $34,861.72 | 44,317 |
| 12/01/2025 | DDS | 92 | Direct | COM | $193.86 | $17,834.91 | 44,496 |
| 12/01/2025 | DDS | 47 | Direct | COM | $195.80 | $9,202.54 | 44,270 |
| 12/01/2025 | DDS | 4 | Direct | COM | $196.35 | $785.38 | 44,266 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research